-
2-(Furan-2-yl)-1-methyl-N-(3,4,5-trimethoxyphenyl)-1H-imidazo[4,5-c]pyridin-6-amine
-
BD014723151642839-27-798%
-
¥3190.0100mg
-
Methyl (E)-5-(2-(5-nitrofuran-2-yl)vinyl)furan-2-carboxylate
-
BD3823624269-96-395%
-
¥1650.05mg
-
4-(4-Fluoro-3-((pyridin-2-ylmethyl)carbamoyl)phenyl)-N-(1H-indazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide
-
BD7647951813527-81-998%
-
¥1157.05mg
-
4-(4-Fluorophenyl)-N-(1H-indazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide
-
BD00781945817194-38-097%
-
¥117.05mg
-
2-(Cyclopropanecarboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide
-
BD764740329221-38-798%
-
¥331.05mg
-
1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-5-oxopyrrolidine-3-carboxylic acid
-
BD496739260555-42-897%
-
¥1495.01g
-
N-(2,6-Difluorobenzyl)-3-(((4-propyl-5-(pyrimidin-4-yl)-4H-1,2,4-triazol-3-yl)methyl)amino)benzamide
-
BD01305900865609-72-997%
-
¥4653.010mg
-
GRK5-IN-4
-
BD015831912410794-89-598%
-
¥
-
KR-39038
-
BD015864742770300-35-998%
-
¥
-
GRK2 Inhibitor 2
-
BD023626212592436-21-898%
-
¥
-
GRK6-IN-2
-
BD014894432677786-27-398%
-
¥
-
GSK317354A
-
BD01863310874119-13-898%
-
¥
-
CCG-273463
-
BD015853842750413-99-998%
-
¥
-
(R,Z)-3-((4-(2-Chloroacetamido)-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-N-(1-(4-fluorophenyl)ethyl)-2-oxoindoline-5-carboxamide
-
BD015705442750414-35-695%
-
¥
-
N-((2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine
-
BD2197625423-98-395+%
-
¥6117.0250mg
-
GSK466317A
-
BD01849810864082-48-498%
-
¥
-
GRK5-IN-3
-
BD015607292410793-22-398%
-
¥
-
CCG-271423
-
BD015866372750413-88-698%
-
¥
-
GSK299115A
-
BD01841150864082-35-998%
-
¥
-
GRK6-IN-1
-
BD015131122677786-61-598%
-
¥